Brief: Biogen Q1 Adjusted EPS USD 3.57 Vs. IBES Estimate USD 2.77
29/04/2026 11:10
Apr 29 (Reuters) - Biogen Q1 revenue USD 2,500 million vs. IBES estimate USD 2,255 million. Q1 EPS USD 2.15 outlook FY adjusted EPS USD 14.25-15.25 vs. IBES estimate USD 15
Recent news on Biogen
See all newsHealth Rounds: Old cancer drug may help restore fertility for certain women
U.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
Biogen rises; co scales back drug programs acquired through $5.6 bln Apellis deal
Biogen scales back Apellis programs, trims research roles after $5.6 billion buyout